患有急性慢性肝衰竭的患者的治疗性血交换改善了生存率 - - 一个更新的元分析
Santhosh E Kumar1, Kausala Sithamparapillai2, Ashok Kumar Choudhury3
1Department of Hepatology, Christian Medical College, Vellore, India.
概括
血交换 (PLEX) 显著提高了急性慢性肝衰竭 (ACLF) 患者的生存率. 与标准医疗治疗相比,这种治疗可以减少30天,90天和长达一年的死亡率.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 关键护理医学 关键护理医学
- 免疫学 免疫学 免疫学
背景情况:
- 急性至慢性肝衰竭 (ACLF) 是一种严重的临床综合征,其特点是器官衰竭和高短期死亡率.
- 血交换 (PLEX) 是越来越多地用于ACLF患者的治疗方式.
研究的目的:
- 评估PLEX在治疗被诊断患有ACLF的患者中的疗效.
- 在ACLF患者中,比较PLEX和标准医疗疗 (SMT) 之间的生存结果.
主要方法:
- 进行了系统性审查和元分析,包括23项研究,涉及5336名ACLF患者.
- 研究将PLEX与SMT在各种ACLF定义和病因学方面进行了比较.
- 主要结局是30天生存期,使用随机效应模型进行分析.
主要成果:
- 与SMT相比,PLEX显著降低了30天死亡率 (RR 0.70) 和90天死亡率 (RR 0.81).
- 一年生存率也显示了PLEX的改善 (RR 0.85).
- 在与HBV相关的和与酒精相关的ACLF亚组中观察到显著的死亡率降低;常见的不良反应包括皮疹和过敏反应.
结论:
- 对于ACLF患者来说,PLEX在治疗后长达一年的时间内提供了显著的生存益处.
- 这些发现支持PLEX作为改善ACLF结果的有效治疗选择.
- 在不同ACLF定义和病因学方面,PLEX证明了更好的生存率.
更多相关视频
相关概念视频
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
386
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
386
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
360
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
360
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
274
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
274
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
1.1K
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
1.1K
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
385
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
385
01:28Kidney Transplant I: Introduction
849
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
849